Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.SSE: 603707

Announcement on Participation in Subscription of Private Fund Units by Wholly-owned Subsidiary

· Issued by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 13 pages · Chinese

On 6ix: 6ix.com/news/nanjing-king-friend-biochemical-pharmaceutical-co-ltdannouncement-on-participation-in-subscription-of-private-fund-units-by-wholly-owned-subsidiary

Release

Announcement on Participation in Subscription of Private Fund Units by Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. on 6ix

Earlier from Nanjing King-friend Biochemical Pharmaceutical

Later from Nanjing King-friend Biochemical Pharmaceutical

All Nanjing King-friend Biochemical Pharmaceutical news releases